Vectra 3D

RSS

dinotefuran, permethrin, and pyriproxyfen

Authorised
This medicine is authorised for use in the European Union.

Overview

Vectra 3D is a veterinary medicine used on dogs to treat and prevent flea and tick infestations and to repel sand flies, mosquitoes and stable flies. Its actions last for up to a month, and it prevents fleas from hatching and developing for two months. Vectra 3D contains three active substances: dinotefuran, pyriproxyfen and permethrin.

This EPAR was last updated on 20/06/2019

Authorisation details

Product details
Name
Vectra 3D
Agency product number
EMEA/V/C/002555
Active substance
  • dinotefuran
  • pyriproxyfen
  • permethrin
International non-proprietary name (INN) or common name
dinotefuran, permethrin, and pyriproxyfen
Species
Dogs
Anatomical therapeutic chemical veterinary (ATCvet) codes
QP53AC54
Publication details
Marketing-authorisation holder
Ceva Sante Animale
Revision
4
Date of issue of marketing authorisation valid throughout the European Union
04/12/2013
Contact address

10 Av. de La Ballastière
33500 Libourne
France

Product information

21/03/2019 Vectra 3D - EMEA/V/C/002555 - II/0011

Contents

Please note that the size of the above document can exceed 50 pages.

You are therefore advised to be selective about which sections or pages you wish to print.

Pharmacotherapeutic group

permethrin, combinations

Therapeutic indication

  • Treatment and prevention of flea infestation (Ctenocephalides felis and Ctenocephalides canis).
  • Treatment and prevention of tick infestation (Rhipicephalus sanguineus, Dermacentor reticulatus, Ixodes ricinus).
  • Prevention of biting from sand flies (Phlebotomus perniciosus), mosquitoes (Culex pipiens, Aedes aegypti) and stable flies (Stomoxys calcitrans).
  • Treatment of mosquito (Aedes aegypti) and stable fly (Stomoxys calcitrans) infestation.

Assessment history

How useful was this page?

Add your rating
Average
2 ratings